| P50 | author | Adam Bisaga | Q39194090 |
| | Piotr Popik | Q58958272 |
| P2860 | cites work | Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification | Q28240310 |
| | The neural basis of drug craving: an incentive-sensitization theory of addiction | Q29547475 |
| | Pharmacological treatment of alcohol dependence: a review of the evidence | Q33596810 |
| | A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE. | Q34260580 |
| | Excitatory amino acids as a final common pathway for neurologic disorders. | Q34321926 |
| | Inhibitory effects of ibogaine on cocaine self-administration in rats | Q34344843 |
| | The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction | Q34391645 |
| | Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. | Q34415261 |
| | Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization | Q34420110 |
| | Molecular and cellular basis of addiction | Q34440561 |
| | The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward | Q34453945 |
| | Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons | Q34461273 |
| | Dextromethorphan. An overview of safety issues | Q35704240 |
| | Cellular mechanisms of behavioral sensitization to drugs of abuse | Q36330241 |
| | Diazepam dependence prevented by glutamate antagonists | Q36437873 |
| | Clonidine blocks acute opiate-withdrawal symptoms | Q39506991 |
| | Medication development of ibogaine as a pharmacotherapy for drug dependence. | Q40850975 |
| | Are detoxification programmes effective? | Q40933216 |
| | The NMDA antagonist dizocilpine (M K801) attenuates tolerance to nicotine in rats. | Q52300234 |
| | Conditioned narcotic withdrawal in humans. | Q52307240 |
| | d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study | Q57016586 |
| | Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat | Q59544956 |
| | Evidence for alcohol anti-craving properties of memantine | Q59544957 |
| | The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures | Q68301427 |
| | MK-801 potently inhibits alcohol withdrawal seizures in rats | Q68451317 |
| | Clonidine in morphine withdrawal. Differential effects on signs and symptoms | Q68944527 |
| | The effect of MK-801 and SCH23390 on the expression and sensitization of morphine-induced oral stereotypy | Q70865211 |
| | Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation | Q71413936 |
| | Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat | Q71546490 |
| | The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice | Q71554229 |
| | A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal | Q71605036 |
| | Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system | Q71681032 |
| | Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine | Q72113758 |
| | MK-801 prevents the development of behavioral sensitization during repeated morphine administration | Q72482348 |
| | Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation | Q72663094 |
| | Opiate withdrawal with dextromethorphan | Q73196349 |
| | Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats | Q73326348 |
| | Ethanol-reinforced behaviour in the rat: effects of uncompetitive NMDA receptor antagonist, memantine | Q77354701 |
| | The effect of lamotrigine on naloxone-precipitated opiate withdrawal | Q77504461 |
| | Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice | Q78228737 |
| | Efficacy of disulfiram: a reply to Hughes and Cook | Q95800261 |
| | Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors. | Q51677120 |
| | Amantadine may facilitate detoxification of cocaine addicts | Q51683092 |
| | Treatment of Cocaine Dependence in Methadone Maintenance Clients: A Pilot Study Comparing the Efficacy of Desipramine and Amantadine | Q51701097 |
| | Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. | Q51761695 |
| | Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. | Q51797471 |
| | Dizocilpine prevents the development of tolerance to ethanol-induced error on a circular maze test. | Q52048274 |
| | Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801 | Q52052445 |
| | The NMDA receptor antagonist dizocilpine differentially affects environment-dependent and environment-independent ethanol tolerance. | Q52059714 |
| | Blockade of chronic tolerance to ethanol by the NMDA antagonist, (+)-MK-801. | Q52065479 |
| | Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration. | Q52168905 |
| | The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats. | Q52184014 |
| | Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. | Q52191419 |
| | NMDA receptor antagonists prevent conditioned activation of intracranial self-stimulation in rats. | Q52194439 |
| | The expression of both amphetamine-conditioned place preference and pentylenetetrazol-conditioned place aversion is attenuated by the NMDA receptor antagonist (+/-)-CPP. | Q52201682 |
| | N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. | Q52207692 |
| | An NMDA receptor antagonist reduces ethanol preference in untrained but not trained rats. | Q52211639 |
| | The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats. | Q52217463 |
| | Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. | Q52228738 |
| | Possible abuse potential of the NMDA antagonist MK-801. | Q52245224 |
| | The dysphoria of heroin addiction. | Q52264921 |
| | Factors that predict individual vulnerability to amphetamine self-administration. | Q52266857 |
| | Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination. | Q52277966 |
| | A preliminary investigation of ibogaine: case reports and recommendations for further study | Q41028052 |
| | N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development | Q41070644 |
| | Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine | Q41104236 |
| | Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors | Q41313856 |
| | Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies. | Q41509275 |
| | Neurobiological similarities in depression and drug dependence: a self-medication hypothesis | Q41705103 |
| | The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants | Q41749963 |
| | Safety review of adult clinical trial experience with lamotrigine | Q41753210 |
| | Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists | Q41851245 |
| | Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence | Q42271310 |
| | Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine | Q42547161 |
| | Comparison of Amantadine and Desipramine Combined with Psychotherapy for Treatment of Cocaine Dependence | Q43860906 |
| | 2-Amino-7-phosphonoheptanoic acid, a selective antagonist of N-methyl-D-aspartate, prevents barbital withdrawal-induced convulsions and the elevation of cerebellar cyclic GMP in dependent rats | Q44188325 |
| | The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal | Q44333382 |
| | Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists | Q44350688 |
| | Pharmacotherapy improves treatment outcome in depressed cocaine addicts. | Q45986086 |
| | Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration? | Q46204457 |
| | GABA and nucleus accumbens glutamate neurotransmission modulate ethanol self-administration in rats | Q46270538 |
| | Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro | Q46457268 |
| | Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex | Q47861304 |
| | Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain | Q47861314 |
| | Nitric oxide synthesis inhibition does not affect brain stimulation reward | Q48109955 |
| | Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward | Q48200288 |
| | Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. | Q48230956 |
| | Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons | Q48248162 |
| | Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization | Q48267682 |
| | Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors. | Q48344658 |
| | NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat | Q48418437 |
| | The involvement of NMDA receptors in acute and chronic effects of ethanol | Q48476370 |
| | Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist | Q48586006 |
| | Homologies and differences in the action of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence. | Q48608728 |
| | The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission | Q48612417 |
| | Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine | Q48638665 |
| | Synergistic effects of cocaine and dizocilpine (MK-801) on brain stimulation reward | Q48682122 |
| | Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress | Q48710539 |
| | Conditioning factors in drug abuse: can they explain compulsion? | Q48722496 |
| | Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy | Q48729145 |
| | NMDA antagonist inhibits rapid tolerance to ethanol | Q48760472 |
| | Effects of post-ethanol administration of NMDA and non-NMDA receptor antagonists on the development of ethanol tolerance in C57B1 mice | Q48813495 |
| | Intraaccumbens administration of NMDA receptor antagonist (+/-)-CPP prevents locomotor activation conditioned by morphine and amphetamine in rats | Q48896168 |
| | Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats | Q48939856 |
| | The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence | Q49021766 |
| | D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes | Q49095632 |
| | The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans. | Q51484451 |
| | Dextromethorphan reduces intravenous cocaine self-administration in the rat. | Q51546243 |
| | Effects of nitric oxide synthase inhibitors on cocaine sensitization. | Q51550015 |
| | Systemic pretreatment with MK-801 (dizocilpine) increases breaking points for self-administration of cocaine on a progressive-ratio schedule in rats. | Q51558396 |
| | Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial. | Q51571420 |
| | Inhibition of nitric oxide synthesis reduces intravenous cocaine self-administration in the rat. | Q51580592 |
| | Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. | Q51584375 |
| | D-cycloserine enhances rapid tolerance to ethanol motor incoordination. | Q51590732 |
| | Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients. | Q51593046 |
| | The NMDA receptor and cocaine: Evidence that MK-801 can induce behavioral sensitization effects | Q51597277 |
| | Evidence for N-methyl-d-aspartate receptor mediation of cocaine induced corticosterone release and cocaine conditioned stimulant effects | Q51602273 |
| | Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy. | Q51607358 |
| | L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. | Q51675396 |
| P433 | issue | 1 | |
| P304 | page(s) | 1-15 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Drug and Alcohol Dependence | Q5308875 |
| P1476 | title | In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists | |
| P478 | volume | 59 | |